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Background
Beta-lactam (BLs) antibiotics are among the drugs most
frequently eliciting allergic reactions, thus posing an
important clinical problem. Protein haptenation plays a
key role in immunological reactions to BLs and this pro-
cess is considered necessary for the activation of the
immune system. Therefore, it is of interest to develop
tools to monitor this process. We have synthesized a bioti-
nylated amoxicillin derivative (AX-B) to be used in the
characterization of protein haptenation by amoxicillin
(AX).
Methods
AX-B was obtained binding a biotin moiety at the lateral
chain of AX. The recognition of AX-B by IgE of allergic
patients was analyzed by RAST inhibition. AX and AX-B
were used for the in vitro modification of proteins in serum
and in cell culture. Modified proteins were separated by
SDS-PAGE and detected by Western blot using an anti-AX
antibody (for AX-modification) or HRP-streptavidin (for
AX-B-modification). Distribution of intracellular protein
adducts with AX-B was analyzed by confocal microscopy.
Results
AX-B showed a chemical reactivity similar to AX and
competition studies suggested that AX-B and AX can
modify the same targets. AX and AX-B behaved similarly
in RAST inhibition studies with sera of patients with non-
selective allergy to BLs, whereas competition by AX-B was
poorer with sera of AX-selective patients. AX-B allowed
the detection of protein adducts with high sensitivity. This
derivative bound to all of the previously identified major
AX targets in serum but made possible to detect some
new targets. In addition, in cell culture, AX-B protein
adducts could be detected intracellularly.
Conclusions
AX-B may constitute a valuable tool for the identification
of AX targets with high sensitivity. The identity of novel
AX-B targets will be the subject of future studies.
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